Figures & data
Table 1. Baseline characteristics of all patients with postsurgical neuropathic pain.
OM: Oral first-line medication; SSNRI: Selective serotonin-norepinephrine reuptake inhibitor.
![Figure 1. Oral recommended first-line medications documented for the treatment of postsurgical neuropathic pain in the OM group after switch from previous medication (n = 531).OM: Oral first-line medication; SSNRI: Selective serotonin-norepinephrine reuptake inhibitor.](/cms/asset/6ca687ea-9707-473e-9211-1e38a8abb11e/ipmt_a_12344526_f0001.jpg)
Data for nonopioids and mild opioids are not shown.
LMP: Lidocaine 700 mg medicated plaster; OM: Oral medication.
![Figure 2. Change in concomitant medication and in rescue medication over the 24-week observation period.Data for nonopioids and mild opioids are not shown.LMP: Lidocaine 700 mg medicated plaster; OM: Oral medication.](/cms/asset/45f50113-dd14-469b-9443-7ebf18d139ba/ipmt_a_12344526_f0002.jpg)
(A) Change from baseline over the observation period. (B) Improvement versus baseline at end of observation.
PIX: Pain intensity index.
![Figure 3. Average 24-h pain intensity index. (A) Change from baseline over the observation period. (B) Improvement versus baseline at end of observation.PIX: Pain intensity index.](/cms/asset/eb4f4ad2-ea03-48cc-8300-7170fa0cc86a/ipmt_a_12344526_f0003.jpg)